Treating Diseases with Stem Cells

What stem cells can do today opens doorways to even more, tomorrow.
Cord blood stem cell transplants have already changed—and saved—thousands of lives around the world. What’s more, science is honing in on other miraculous uses for these precious cells, potentially impacting countless numbers of lives in the future.

How are cord blood stem cells saving lives now?
Cord blood stem cells have already been used to treat more than 70 diseases, including numerous types of malignancies, anemia's, inherited metabolic disorders and deficiencies of the immune system. The majorities of cord blood transplants to date have been performed in patients less than 18 years old and have been sibling or allergenic (unrelated third party) transplants.

Acute Leukemia's
Acute Lymphoblastic Leukemia (ALL)
Acute Myelogenous Leukemia (AML)
Acute Biphenotypic Leukemia
Acute Undifferentiated Leukemia
Chronic Leukemia's
Chronic Myelogenous Leukemia (CML)
Chronic Lymphocytic Leukemia (CLL)
Juvenile Chronic Myelogenous Leukemia (JCML)
Juvenile Myelomonocytic Leukemia (JMML)
Myelodysplastic Syndromes
Myelodysplastic Syndrome
Refractory Anemia (RA)
Refractory Anemia with Ringed Sideroblasts (RARS)
Refractory Anemia with Excess Blasts (RAEB)
Refractory Anemia with Excess Blasts in Transformation (RAEB-T)
Chronic Myelomonocytic Leukemia (CMML)
Hematopoetic Cell Disorders
Aplastic Anemia (Severe)
Fanconi Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pure Red Cell Aplasia
Myeloproliferative Disorders
Acute Myelofibrosis
Agnogenic Myeloid Metaplasia (myelofibrosis)
Polycythemia Vera
Essential Thrombocythemia
Lymphoproliferative Disorders
Non-Hodgkin's Lymphoma
Hodgkin's disease
Phagocyte Disorders
Chediak-Higashi Syndrome
Chronic Granulomatous Disease
Neutrophil Actin Deficiency
Reticular Dysgenesis
Inherited Metabolic Disorders
Mucopolysaccharidoses (MPS)
Hurler's Syndrome (MPS-IH)
Scheie Syndrome (MPS-IS)
Hunter's Syndrome (MPS-II)
Sanfilippo Syndrome (MPS-III)
Morquio Syndrome (MPS-IV)
Maroteaux-Lamy Syndrome (MPS-VI)
Sly Syndrome, Beta-Glucuronidase Deficiency (MPS-VII)
Adrenoleukodystrophy
Mucolipidosis II (I-cell Disease)
Krabbe Disease
Gaucher's Disease
Niemann-Pick Disease
Wolman Disease
Metachromatic Leukodystrophy
Histiocytic Disorders
Familial Erythrophagocytic Lymphohistiocytosis
Histiocytosis-X
Hemophagocytosis
Inherited Erythrocyte Abnormalities
Beta Thalassemia Major
Sickle Cell Disease
Inherited Immune System Disorders
Ataxia-Telangiectasia
Kostmann Syndrome
Leukocyte Adhesion Deficiency
DiGeorge Syndrome
Bare Lymphocyte Syndrome
Omenn's Syndrome
Severe Combined Immunodeficiency (SCID)
SCID with Adenosine Deaminase Deficiency
Absence of T & B Cells SCID
Absence of T Cells, Normal B Cell SCID
Common Variable Immunodeficiency
Wiskott-Aldrich Syndrome
X-Linked Lymphoproliferative Disorder
Other Inherited Disorders
Lesch-Nyhan Syndrome
Cartilage-Hair Hypoplasia
Glanzmann Thrombasthenia
Osteopetrosis
Inherited Platelet Abnormalities
Amegakaryocytosis / Congenital Thrombocytopenia
Plasma Cell Disorders
Multiple Myeloma
Plasma Cell Leukemia
Waldenstrom's Macroglobulinemia
Other Malignancies
Breast Cancer
Ewing Sarcoma
Neuroblastoma
Renal Cell Carcinoma
Autologous (self) stem cells may not be useful in the treatment of certain of the above diseases.

What new uses for cord blood stem cells are possible in the future?
New medical technology may well use these cells to rebuild cardiac tissue, repair damage due to stroke or spinal cord injuries and reverse the effects of such diseases as multiple sclerosis or Parkinson’s. While the research is in its early stages, the possibilities are extremely promising. And banking your child’s stem cells increases access to any of these technologies in the future.